T2C2 Capital

T2C2 Capital

A venture capital and private equity firm investing in healthcare, information technology, business products, and services sectors.

All edits

Edits on 3 Feb, 2020
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 3 Feb, 2020
Edits made to:
Article (+8/-8 characters)
Article

T2C2 Capital (Technology, Transfer, Commercialisation, Capital) is a venture capital and private equity firm investing in healthcare, information technology, business products, and services sectors that is headquartered in MontrealMontreal, Quebec and was founded in 2003.

Edits on 31 Jan, 2020
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 31 Jan, 2020
Edits made to:
Article (+13/-13 characters)
Article

As of December 2019), T2C2 Capital has made 23 investments, has 1 company in its portfolio, and has made 12 exits. Notable investments made by T2C2 Capital include: Cytochroma, Aegera Therapeutics, Chronogen, LatroQuest, Cytheris, TransPharma Medical, BioAxone Therepautic, Enobia pharmaEnobia pharma, Topigen Pharmaceuticals, Quazal Technologies, and Interomex BioPharmaceuticals.

Edits on 23 Jan, 2020
Carla Faraguna
Carla Faraguna edited on 23 Jan, 2020
Edits made to:
Article (+2/-26 characters)
Article

According to Pitchbook (asAs of December 2019), T2C2 Capital has made 23 investments, has 1 company in its portfolio, and has made 12 exits. Notable investments made by T2C2 Capital include: Cytochroma, Aegera Therapeutics, Chronogen, LatroQuest, Cytheris, TransPharma Medical, BioAxone Therepautic, Enobia pharma, Topigen Pharmaceuticals, Quazal Technologies, and Interomex BioPharmaceuticals.

Edits on 4 Dec, 2019
Dawson Sewell
Dawson Sewell edited on 4 Dec, 2019
Edits made to:
Infobox (+3/--1 properties)
Description (+132 characters)
Article (+670 characters)
Topic thumbnail

T2C2 Capital

A venture capital and private equity firm investing in healthcare, information technology, business products, and services sectors.

Article

T2C2 Capital (Technology, Transfer, Commercialisation, Capital) is a venture capital and private equity firm investing in healthcare, information technology, business products, and services sectors that is headquartered in Montreal, Quebec and was founded in 2003.

Investments

According to Pitchbook (as of December 2019), T2C2 Capital has made 23 investments, has 1 company in its portfolio, and has made 12 exits. Notable investments made by T2C2 Capital include: Cytochroma, Aegera Therapeutics, Chronogen, LatroQuest, Cytheris, TransPharma Medical, BioAxone Therepautic, Enobia pharma, Topigen Pharmaceuticals, Quazal Technologies, and Interomex BioPharmaceuticals.

Infobox
Location
Montreal
Company status
Closed
Founded date
2003
Edits on 11 Jul, 2019
Golden AI"Crunchbase 2013 Snapshot (C) 2013 https://data.crunchbase.com/docs/2013-snapshot#section-using-the-snapshot"
Golden AI edited on 11 Jul, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Is a
Company
Edits on 9 Jul, 2019
Golden AI"Crunchbase 2013 Snapshot (C) 2013 https://data.crunchbase.com/docs/2013-snapshot#section-using-the-snapshot"
Golden AI edited on 9 Jul, 2019
Edits made to:
Infobox (+3 properties)
Infobox
Is a
Venture capital firm
Golden AI"Initial topic creation"
Golden AI created this topic on 9 Jul, 2019
Edits made to:
Topic thumbnail

 T2C2 Capital

A venture capital and private equity firm investing in healthcare, information technology, business products, and services sectors.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.